Imperial Collage Healthcare


Test Background
Levetiracetam (brand name Keppra) is approved for adjunctive therapy in the treatment of partial onset seizures in adults with epilepsy. It is also efficacious in children with partial seizures and there are indications that it may be effective in generalised seizures.

Clinical Indications
Assessment of patient compliance Assessment of suspected toxicity

Reference Range
See report

Sample Required
SST (gold top), serum (red top) or heparin (green top)

Sample Volume
1 mL pre-dose trough sample

Turnaround Time
Up to 6 weeks

Not currently performed in house; this is a referred test.

Filter by A-Z

Select a test from the left to view more details.